BFM
BDSI

Boothbay Fund Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Boothbay Fund Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-341,176
Closed -$1.06M – 2734
2021
Q4 		$1.06M Buy
341,176
+240,680
+239% +$810K 0.02% 720
2021
Q3 		$363K Sell
100,496
-13,598
-12% -$51.3K 0.01% 1237
2021
Q2 		$408K Buy
114,094
+13,982
+14% +$49.3K 0.01% 1108
2021
Q1 		$391K Buy
100,112
+29,889
+43% +$123K 0.01% 1074
2020
Q4 		$295K Buy
70,223
+16,824
+32% +$64.8K 0.01% 958
2020
Q3 		$199K Buy
53,399
+19,629
+58% +$83.5K 0.01% 948
2020
Q2 		$147K Buy
+33,770
New +$152K 0.01% 840
2019
Q2 		– Sell
-19,088
Closed -$101K – 1015
2019
Q1 		$101K Sell
19,088
-67,808
-78% -$310K 0.01% 660
2018
Q4 		$322K Buy
+86,896
New +$305K 0.05% 366

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Boothbay Fund Management's BDSI Position: Q1 2022 in Review

Boothbay Fund Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 341,176 shares — an estimated $1.06M sold.

Boothbay Fund Management first reported a position in BDSI in Q4 2018 and held it in 9 quarters. The position peaked at $1.06M in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Boothbay Fund Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 341,176 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.06M.
  • Boothbay Fund Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2018 and held it in 9 quarters.
  • Boothbay Fund Management's BioDelivery Sciences International, Inc. position peaked at $1.06M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Boothbay Fund Management's 13F filing for Q1 2022, filed 16 May 2022.